In addition to DPEP1, we also found that higher TPX2 expression is associated with poor outcome in two independent cohorts of resected PDAC patients, supporting the oncogenic role of TPX2 in several solid tumors including pancreatic adenocarcinoma [23], [24]. The gene discussed is TPX2; the disease is pancreatic adenocarcinoma.